A rationale for continuing mass antibiotic distributions for trachoma
about
Elimination and eradication of neglected tropical diseases with mass drug administrations: a survey of expertsWhere do we go from here? Prevalence of trachoma three years after stopping mass distribution of antibiotics in the regions of Kayes and Koulikoro, MaliMass drug administration for trachoma: how long is not long enough?Reduction and return of infectious trachoma in severely affected communities in Ethiopia.Estimating household and community transmission of ocular Chlamydia trachomatis.Mass antibiotic treatment alone does not eliminate ocular chlamydial infection.When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countriesThe development of an age-structured model for trachoma transmission dynamics, pathogenesis and control.Importance of coverage and endemicity on the return of infectious trachoma after a single mass antibiotic distributionRisk factors for ocular chlamydia after three mass azithromycin distributions.Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity.The distribution of ocular Chlamydia prevalence across Tanzanian communities where trachoma is decliningControl of trachoma in Australia: a model based evaluation of current interventions.The efficacy of oral azithromycin in clearing ocular chlamydia: mathematical modeling from a community-randomized trachoma trial.Chlamydial infection during trachoma monitoring: are the most difficult-to-reach children more likely to be infected?Enhanced antibiotic distribution strategies and the potential impact of facial cleanliness and environmental improvements for the sustained control of trachoma: a modelling studyImproving our forecasts for trachoma elimination: What else do we need to know?Field transmission intensity of Schistosoma japonicum measured by basic reproduction ratio from modified Barbour's model.Identifying host species driving transmission of schistosomiasis japonica, a multihost parasite system, in ChinaEpidemiology and control of trachoma: systematic review.The distribution of the prevalence of ocular chlamydial infection in communities where trachoma is disappearing.Basic Reproduction Number and Transmission Dynamics of Common Serogroups of Enterohemorrhagic Escherichia coli.Models of epidemics: when contact repetition and clustering should be includedThe epidemiological dynamics of infectious trachoma may facilitate elimination.Prospects for the control of neglected tropical diseases by mass drug administration.Probabilistic forecasts of trachoma transmission at the district level: A statistical model comparisonTwo-day dosing versus one-day dosing of azithromycin in children with severe trachoma in Tanzania.
P2860
Q21562239-F6623E1A-B292-48A1-A840-BECCDBCBCE06Q28474778-2E275174-22CE-477D-8218-15B2292AE408Q28544875-DB2A7949-A4F7-4A3C-A789-3F09FCE4BC51Q33405255-4EBD3316-1238-4EAA-9CDB-7257E19D31B9Q33424445-3A2A4672-F947-4674-8EEE-B0401541CFCEQ33424456-DF3CDC4A-73AF-457C-832A-7EC6D1780460Q33468389-9ACC1B64-362A-426F-8AB1-D5164B5DBB31Q33468392-49C18BA8-CA08-4D31-B7E5-7D15F2A290F8Q33496749-AF38EB9F-4273-4AD0-BD6A-50B5FEB6AEDCQ34105280-B4277097-1F00-44CD-8D2F-FFC0E3B490ACQ34855220-BA20B987-9046-4FB4-880A-9326079284B0Q35223739-F603D3BE-8462-440E-9868-094965982F65Q35363980-52CCF819-3ACA-4796-99E1-54FB81347659Q35571651-57BB9F64-D695-484A-BB06-718C84BA53A6Q35798895-ED4699E1-A257-438B-8FDE-EFAC440F1CCCQ36021861-02E1F01B-9B64-46D0-90AA-AEA71DFEF8E7Q36275318-95A54B39-515C-4B97-A794-42B5AFB8886FQ36885327-5D9FB6C6-7DA9-4B7C-97C7-8563FE237557Q37010766-C4B2218D-6755-483A-8416-F58E68CFA69AQ37165258-A4A1534D-072F-4B66-B1FC-388D405A47ACQ37179222-22418809-B86F-4431-934B-019E8429AD50Q37224095-61A1DD54-C8D3-41C3-BCF1-2E1C9F691AF2Q37259944-7748C18D-3D9E-491B-B009-15FF0D16C24FQ37407454-8861C8F1-D039-4E17-A7C6-BA0A24F497FEQ37557676-1E986A78-2110-42E6-9DD9-C495E91F641FQ37685533-D669EBC0-01C0-4B44-9FC7-736B77EBCB30Q37849443-C2A1BD43-A2D3-4202-B706-4F2FFC8F4726
P2860
A rationale for continuing mass antibiotic distributions for trachoma
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A rationale for continuing mass antibiotic distributions for trachoma
@ast
A rationale for continuing mass antibiotic distributions for trachoma
@en
A rationale for continuing mass antibiotic distributions for trachoma.
@nl
type
label
A rationale for continuing mass antibiotic distributions for trachoma
@ast
A rationale for continuing mass antibiotic distributions for trachoma
@en
A rationale for continuing mass antibiotic distributions for trachoma.
@nl
prefLabel
A rationale for continuing mass antibiotic distributions for trachoma
@ast
A rationale for continuing mass antibiotic distributions for trachoma
@en
A rationale for continuing mass antibiotic distributions for trachoma.
@nl
P2093
P2860
P50
P356
P1476
A rationale for continuing mass antibiotic distributions for trachoma
@en
P2093
David C Lee
Elizabeth Yi
John P Whitcher
Kathryn J Ray
Kevin C Hong
Muluken Melese
Takele Lakew
P2860
P2888
P356
10.1186/1471-2334-7-91
P577
2007-08-07T00:00:00Z
P5875
P6179
1035675946